FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Bid/Ask 14:20:18 23/05/2024 BST | After market 20:09:32 | |||
| 8.98 EUR | -8.18% |
|
6.21 | -30.85% |
| Current month | +17.27% | ||
| 1 month | +198.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 8.98 | -8.18% |
| 22/05/24 | 9.78 | -9.11% |
| 21/05/24 | 10.76 | -19.94% |
| 20/05/24 | 13.44 | +7.61% |
| 17/05/24 | 12.49 | -30.69% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 02:20 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD462W |
| ISIN | DE000HD462W5 |
| Date issued | 27/03/2024 |
| Strike | 204.8 $ |
| Maturity | Unlimited |
| Parity | 2.34 : 1 |
| Emission price | 10.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.02 € |
|---|---|
| Lowest since issue | 2.49 € |
| Spread | 0.4 € |
| Spread % | 6.22% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.2
USD
Average target price
287.3
USD
Spread / Average Target
+27.57%
- Stock Market
- Certificates
- Certificat
